» Articles » PMID: 25003331

Maternal Glomerular Filtration Rate in Pregnancy and Fetal Size

Overview
Journal PLoS One
Date 2014 Jul 9
PMID 25003331
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The relationship of maternal glomerular filtration rate (GFR) in pregnancy to fetal size needs to be better characterized as it impacts an ongoing debate about confounding effect of maternal GFR in investigations of important environmental contaminants. We aimed to characterize the size of the association between maternal GFR and infant birth weight.

Materials And Methods: A sub-cohort of 953 selected women (470 women with and 483 women without preeclampsia) in the Norwegian Mother and Child Cohort (MoBa), recruited during 2003-2007 were analyzed. GFR in the second trimester was estimated based on plasma creatinine. Birth weight was ascertained from the Medical Birth Registry of Norway. Multivariate linear regression was used to evaluate the association between maternal GFR in second trimester (estimated by the Cockroft-Gault [GFR-CG] and the modification of diet in renal disease [GFR-MDRD] formulas) and infant birth weight. Partial correlation coefficients were also calculated.

Results: Maternal GFR-CG (β: 0.73 g/ml/min, p = 0.04) and GFR-MDRD (β: 0.83 g/ml/min, p = 0.04) were associated with infant birth weight in models adjusted for maternal weight in kilograms, preeclampsia, and gestational age at delivery (days). Partial correlation coefficients for the association between infant birth weight and GFR were 0.07 for both formulas. Although the birth weight-GFR association was stronger among the women with preeclampsia, the difference from women without preeclampsia was not statistically significant.

Conclusion: These data support an association between GFR during pregnancy and infant birth weight, and indicate that GFR may confound selected epidemiologic associations.

Citing Articles

Associations of PFAS concentrations during pregnancy and midlife with bone health in midlife: Cross-sectional and prospective findings from Project Viva.

Lin P, Cardenas A, Rokoff L, Rifas-Shiman S, Zhang M, Botelho J Environ Int. 2024; 194:109177.

PMID: 39667063 PMC: 11683763. DOI: 10.1016/j.envint.2024.109177.


Maternal and Paternal Preconception Serum Concentrations of Per and Polyfluoroalkyl Substances in Relation to Birth Outcomes.

Zhang Y, Mustieles V, Martin L, Sun Y, Hillcoat A, Fang X Environ Sci Technol. 2024; 58(6):2683-2692.

PMID: 38290209 PMC: 10924800. DOI: 10.1021/acs.est.3c07954.


Pregnancy-related hemodynamic biomarkers in relation to trimester-specific maternal per - and polyfluoroalkyl substances exposures and adverse birth outcomes.

Taibl K, Liang D, Dunlop A, Barr D, Smith M, Steenland K Environ Pollut. 2023; 323:121331.

PMID: 36813097 PMC: 10023492. DOI: 10.1016/j.envpol.2023.121331.


Factors Associated with the Severity of Pregnancy-Related Hypertensive Disorder: Significance of Clinical, Laboratory, and Histopathological Features.

An H, Song D, Kim Y, Jo H, Baek J, Kim H Diagnostics (Basel). 2022; 12(9).

PMID: 36140589 PMC: 9498006. DOI: 10.3390/diagnostics12092188.


Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort.

Preston E, Hivert M, Fleisch A, Calafat A, Sagiv S, Perng W Environ Int. 2022; 165:107335.

PMID: 35696844 PMC: 9348856. DOI: 10.1016/j.envint.2022.107335.


References
1.
Starling A, Engel S, Richardson D, Baird D, Haug L, Stuebe A . Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study. Am J Epidemiol. 2014; 179(7):824-33. PMC: 3969534. DOI: 10.1093/aje/kwt432. View

2.
Magnus P, Irgens L, Haug K, Nystad W, Skjaerven R, Stoltenberg C . Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol. 2006; 35(5):1146-50. DOI: 10.1093/ije/dyl170. View

3.
Spencer E, Appleby P, Davey G, Key T . Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr. 2002; 5(4):561-5. DOI: 10.1079/PHN2001322. View

4.
Clark S, Youngman L, Palmer A, Parish S, Peto R, Collins R . Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies. Int J Epidemiol. 2003; 32(1):125-30. DOI: 10.1093/ije/dyg023. View

5.
Knopp R, Bergelin R, Wahl P, Walden C . Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes. 1985; 34 Suppl 2:71-7. DOI: 10.2337/diab.34.2.s71. View